CTOs on the Move

Humedica, Inc.

www.humedica.com

 
Humedica, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Brighton, MA. To find more information about Humedica, Inc., please visit www.humedica.com
  • Number of Employees: 1K-5K
  • Annual Revenue: $1-10 Million
  • www.humedica.com
  • 1380 Soldiers Field Rd
    Brighton, MA USA 02135-1023
  • Phone: 617.475.3800

Executives

Name Title Contact Details

Similar Companies

23andMe

23andMe is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Lincoln County Health System

The Lincoln County Health System is a full-service, health care system, which serves Lincoln County. The Lincoln County Health System is a multi-faceted health care system whose mission is to provide life-long health care for the people it serves. In addition to a 59-bed acute care hospital, the system consists of a freestanding rehabilitation and wellness center, a 240 bed licensed nursing home, a home health and hospice agency, and an ambulance/EMS service. The facilities are county-owned and are governed by the Lincoln County Health System Board of Trustees.

Innovagraft Biologics

Innovagraft Biologics is a Wayzata, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ameri-Pac Inc

Ameri-Pac, Inc. is a manufacturer of animal health and nutrition specialty products for the pet food, companion animal, farm animal, veterinary and aquaculture industries. We are a family-owned business with three generations involved in the day-to-day

RaNA Therapeutics

RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.